Association of Serotonin Transporter Promoter Polymorphism (5-HTTLPR) with Microscopic Colitis and Ulcerative Colitis

Digestive Diseases and Sciences

Volumn 60, Issue 4, 2015, Pages 887-894

  Sikander, Arbab ^a   Sinha, Saroj Kant ^b   Prasad, Kaushal Kishor ^b   Rana, Satya Vati ^b,c  

^a JAZAN UNIVERSITY   (Saudi Arabia)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^c NONE   (India)

Author keywords

Microscopic colitis; Serotonin; Serotonin transporter promoter polymorphism; Ulcerative colitis

Indexed keywords

SEROTONIN; SEROTONIN TRANSPORTER; SLC6A4 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; BLOOD; CASE CONTROL STUDY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; MALE; MICROSCOPIC COLITIS; MIDDLE AGED; PROMOTER REGION; PROSPECTIVE STUDY; SEX DIFFERENCE; ULCERATIVE COLITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COLITIS, MICROSCOPIC; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; PROSPECTIVE STUDIES; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX FACTORS; YOUNG ADULT;

EID: 84934289127     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-014-3482-y     Document Type: Article

References (39)

1. Gershon MD. Serotonin and its implication for the management of irritable bowel syndrome. Rev Gastroenterol Disord. 2003;3:S25–S34.
2. Ham TS. Regional distribution and relative frequency of gastrointestinal endocrine cells in large intestines of C57BL/6 mice. J Vet Sci. 2002;3:233–238.
3. Khan WI, Ghia JE. Gut hormones: emerging role in immune activation and inflammation. Clin Exp Immunol. 2010;161:19–27.
4. Kim DY, Camilleri M. Serotonin: a mediator of the brain-gut connection. Am J Gastroenterol. 2000;95:2698–2709.
5. Gershon MD, Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology. 2007;132:397–414.
6. Chen JX, Pan H, Rothman TP, Wade PR, Gershon MD. Guinea pig 5-HT transporter: cloning, expression, distribution, and function in intestinal sensory reception. Am J Physiol. 1998;275:G433–G448.
7. Heils A, Teufel A, Petri S, Stöber G, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996;66:2621–2624.
8. Lesch KP, Bengel D, Heils A, Sabol SZ, et al. Association of anxiety related traits with a polymorphism in the serotonin transporter gene regulatory region. Science. 1996;274:1527–1531.
9. Ahonen A, Kyösola K, Penttilä O. Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res. 1976;8:1–7.
10. Coates MD, Mahoney CR, Linden DR, Sampson JE, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome. Gastroenterology. 2004;126:1657–1664.
11. Magro F, Vieira-Coelho MA, Fraga S, Serrão MP, et al. Impaired synthesis or cellular storage of norepinephrine, dopamine, and 5-hydroxytryptamine in human inflammatory bowel disease. Dig Dis Sci. 2002;47:216–224.
12. Ghia JE, Li N, Wang H, Collins M, et al. Serotonin has a key role in pathogenesis of experimental colitis. Gastroenterology. 2009;137:1649–1660.
13. Linden DR, Chen JX, Gershon MD, Sharkey KA, Mawe GM. Serotonin availability is increased in mucosa of guinea pigs with TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol. 2003;285:G207–G216.
14. Oshima S, Fujimura M, Fukimiya M. Changes in number of serotonin-containing cells and serotonin levels in the intestinal mucosa of rats with colitis induced by dextran sodium sulfate. Histochem Cell Biol. 1999;112:257–263.
15. Minderhoud IM, Oldenburg B, Schipper ME, ter Linde JJ, Samsom M. Serotonin synthesis and uptake in symptomatic patients with Crohn’s disease in remission. Clin Gastroenterol Hepatol. 2007;5:714–720.
16. Isgar B, Harman M, Kaye MD, Whorwell PJ. Symptoms of irritable bowel syndrome in ulcerative colitis in remission. Gut. 1983;24:190–192.
17. Nyhlin N, Bohr J, Eriksson S, Tysk C. Microscopic colitis: a common and an easily overlooked cause of chronic diarrhoea. Eur J Intern Med. 2008;19:181–187.
18. Pardi DS, Smyrk TC, Tremaine WJ, Sandborn WJ. Microscopic colitis: a review. Am J Gastroenterol. 2002;97:794–802.
19. Bohr J. A review of collagenous colitis. Scand J Gastroenterol. 1998;33:2–29.
20. Fernández-Bañares F. Epidemiology of microscopic colitis. In: Colombel JF, Jewell DP, Pena AS, Tromm A, Warren BF, eds. Colitis: Diagnosis and Therapeutics Strategies. Falk symposia series 147. Dordrecht: Springer; 2006: 25–32.
21. Fernández-Bañares F, Esteve M, Espinós JC, et al. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol. 2007;102:324–330.
22. Beaugerie L, Pardi D. Review article: drug-induced microscopic colitis—a proposal for a scoring system and review of the literature. Alimen Pharm Therap. 2005;22:277–284.
23. Tagkalidis P, Bhathal P, Gibson P. Microscopic colitis. J Gastroenterol Hepatol. 2002;17:236–248.
24. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2–6.
25. Lahiri DK, Nurhberger JI. A rapid non enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acid Res. 1991;19:5444.
26. Sikander A, Rana SV, Sinha SK, et al. Serotonin transporter promoter variant: analysis in Indian IBS patients and control population. J Clin Gastroenterol. 2009;43:957–961.
27. Gershon MD. Plasticity in serotonin control mechanisms in the gut. Curr Opin Pharmacol. 2003;3:600–607.
28. Kellum JM, Albuquerque FC, Stoner MC, Harris RP. Stroking human jejunal mucosa induces 5-HT release and Cl- secretion via afferent neurons and 5-HT4 receptors. Am J Physiol. 1999;277:G515–G520.
29. El-Salhy M, Danielsson A, Stenling R, Grimelius L. Colonic endocrine cells in inflammatory bowel disease. J Intern Med. 1997;242:413–419.
30. Stoyanova II, Gulubova MV. Mast cells and inflammatory mediators in chronic ulcerative colitis. Acta Histochem. 2002;104:185–192.
31. Bishop AE, Pietroletti R, Taat CW, Brummelkamp WH, Polak JM. Increased populations of endocrine cells in Crohn’s ileitis. Virchows Arch A Pathol Anat Histopathol. 1987;410:391–396.
32. Wisniewska-Jarosinska M, Boznanska-Swietaszek P, Harasiuk A, Mokwinska M, Stec-Michalska K, Chojnacki J. 24-hour urinary 5-hydroxyindole acetic acid excretion in patients with ulcerative colitis. Pol Merkur Lekarski. 2009;26:452–454.
33. Verity MA, Mellunkoff SM, Frankland M, Greipel M. Serotonin content and argentaffin and Paneth cell changes in ulcerative colitis. Gastroenterology. 1962;43:24–31.
34. Baez-Giangreco A, Afzal M, Antonious J, Laajam MA, Zargar SA. Collagenous colitis: a case report with study of the neuroendocrine markers. Saudi J Gastroenterol. 1999;5:36–39.
35. Docherty M. Elevated serotonin associated with collagenous colitis. Am J Gastroenterol. 2010;105:1449.
36. Narla NP, Smyrk TC, Pardi DS, Tung J. Clinical features and treatment responses in pediatric lymphocytic and collagenous colitis. J Pediatr Gastroenterol Nutr. 2013;57:557–561.
37. Nakamura M, Ueno S, Sano A, Tanabe H. The human serotonin transporter gene linked polymorphism (5-HTTLPR) shows ten novel allelic variants. Mol Psychiatry. 2000;5:32–38.
38. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78:815–826.
39. Shiotani A, Kusunoki H, Kimura Y, Ishii M, et al. S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci. 2013;58:2314–2323.